Overview

Marendis Therapeutics is a TechBio company that predicts cancer’s escape routes and develops first-in-class precision therapies to block them preemptively. Our signaling intelligence platform, EVOLVE, combines phosphoproteomics-driven multiomics with AI to uncover adaptive signaling mechanisms, predict drug resistance, and reveal novel therapeutic vulnerabilities.